Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Board for the Modified REGENESIS Phase IIb Stroke Trial print release pdf
Stem Cell Therapeutics Corp. Receives 'No Objection Letter' From Health Canada for the Phase IIa Clinical Trial in Traumatic Brain Injury Patients print release pdf
Stem Cell Therapeutics Corp. Announces Second Positive Review by Data Safety and Monitoring Board for the Modified REGENESIS Phase IIb Stroke Trial and Provides Corporate Update print release pdf
